BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15882710)

  • 1. Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation.
    Lemack GE; Hawker K; Frohman E
    Urology; 2005 May; 65(5):854-7. PubMed ID: 15882710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
    Fletcher SG; Dillon BE; Gilchrist AS; Haverkorn RM; Yan J; Frohman EM; Lemack GE
    Mult Scler; 2013 Aug; 19(9):1169-74. PubMed ID: 23339136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.
    Ineichen BV; Schneider MP; Hlavica M; Hagenbuch N; Linnebank M; Kessler TM
    Mult Scler; 2018 Apr; 24(4):529-534. PubMed ID: 28367674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between bladder echography and urodynamic examination in patients with multiple sclerosis].
    Vespasiani G; Giannantoni A; Collura G; Silecchia A; Finazzi Agrò E; Manca di Villahermosa S; Virgili G
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):71-4. PubMed ID: 9162379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis.
    Onal B; Siva A; Buldu I; Demirkesen O; Cetinel B
    Int Braz J Urol; 2009; 35(3):326-33. PubMed ID: 19538768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis.
    Lemack GE; Frohman EM; Zimmern PE; Hawker K; Ramnarayan P
    Urology; 2006 May; 67(5):960-4. PubMed ID: 16635509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures.
    Lemack GE; Frohman E; Ramnarayan P
    Urology; 2007 May; 69(5):893-7. PubMed ID: 17482929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the utility of urodynamics, including ambulatory, and 24 h monitoring, in predicting upper urinary tract damage in neuro-urological patients and other lower urinary tract dysfunction? ICI-RS 2017.
    Rantell A; Lu Y; Averbeck MA; Badawi JK; Rademakers K; Tarcan T; Cardozo L; Djurhuus JC; Castro-Diaz D
    Neurourol Urodyn; 2018 Jun; 37(S4):S25-S31. PubMed ID: 30024052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urologic complications of multiple sclerosis. 180 cases].
    Amarenco G; Bosc S; Boiteau F
    Presse Med; 1996 Jun; 25(22):1007-10. PubMed ID: 8692784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and the neurogenic bladder.
    Rashid TM; Hollander JB
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):615-29. PubMed ID: 9894113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is baseline routine renal ultrasound indicated for all MS patients?
    Títoff IB; Titoff V; Scott TF
    Postgrad Med J; 2020 Apr; 96(1134):194-196. PubMed ID: 31611266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamics and multiple sclerosis.
    Hinson JL; Boone TB
    Urol Clin North Am; 1996 Aug; 23(3):475-81. PubMed ID: 8701560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
    Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of the urologic consequences of neurologic disease.
    Kotkin L; Milam DF
    Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction.
    Kabay S; Kabay SC; Yucel M; Ozden H; Yilmaz Z; Aras O; Aras B
    Neurourol Urodyn; 2009; 28(8):964-8. PubMed ID: 19373898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genitourinary changes in multiple sclerosis: the need for a urodynamic study].
    Martín C; Salinas J; Fernández-Durán A; Fernández-Gómez J; Jiménez N; Gangoiti L
    Rev Neurol; 2000 Apr 1-15; 30(7):643-8. PubMed ID: 10859743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the upper urinary tract function in multiple sclerosis patients.
    Krhut J; Hradílek P; Zapletalová O
    Acta Neurol Scand; 2008 Aug; 118(2):115-9. PubMed ID: 18307573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.
    Kim YH; Goodman C; Omessi E; Rivera V; Kattan MW; Boone TB
    J Urol; 1998 Mar; 159(3):972-6. PubMed ID: 9474196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic study in the neurogenic bladder dysfunction caused by intervertebral disk hernia.
    Dong D; Xu Z; Shi B; Chen J; Jiang X; Wang H
    Neurourol Urodyn; 2006; 25(5):446-50. PubMed ID: 16847921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.